EFFIENT

This brand name is authorized in Brazil, New Zealand, Singapore, Turkey, United States

Active ingredients

The drug EFFIENT contains one active pharmaceutical ingredient (API):

1 Prasugrel UNII G89JQ59I13 - PRASUGREL HYDROCHLORIDE

Prasugrel is an inhibitor of platelet activation and aggregation through the irreversible binding of its active metabolite to the P2Y12 class of ADP receptors on platelets. Since platelets participate in the initiation and/or evolution of thrombotic complications of atherosclerotic disease, inhibition of platelet function can result in the reduction of the rate of cardiovascular events such as death, myocardial infarction, or stroke. Read about Prasugrel

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
EFFIENT Film-coated tablet	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
B01AC22	Prasugrel	B Blood and blood forming organs → B01 Antithrombotic agents → B01A Antithrombotic agents → B01AC Platelet aggregation inhibitors excl. heparin
Discover more medicines within B01AC22

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 530412030008503, 530412030008603, 530412030008703, 530421080018203
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 13517, 13518
Country: SG	Health Sciences Authority	Identifier(s): 13795P, 13796P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699228090348
Country: US	FDA, National Drug Code	Identifier(s): 0002-5121, 0002-5123